Analytical chemistry and stability testing of treatment drugs for substance use disorders.
Active Definitive Contract Awarded Last action
- Contract number
- 75N95024C00021
- Awardee
-
Research Triangle Institute UEI JJHCMK4NT5N3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,852,395
Award facts
- Opportunity
-
- Presolicitation - Analytical Chemistry and Stability Testing of Treatment Drugs for Substance Use Disorders Pre-Solicitation · 75N95024R00045 · Posted Jan 24, 2024
- Contract value 26% obligated
-
- $1,852,395.00 Current, with exercised options
- $7,017,379.00 Potential, with all options
- Completion date 45% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Durham, NC 27709, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $561,139 | |
| Other Administrative Action | $0 | |
| Change Order | $543,704 | |
| Funding Only Action | $747,552 | |
| Original award | $0 |
About this award
The National Institute on Drug Abuse awarded a $7.02 million definitive contract to Research Triangle Institute for analytical chemistry and stability testing of substance use disorder treatment drugs on August 4, 2024, under cost-plus-fixed-fee pricing with no set-aside.
The three-year base period runs from August 4, 2024 through August 3, 2027, with options extending the ultimate completion date to August 3, 2029. Place of performance is Durham, North Carolina.
The originating solicitation calls for analytical method development and validation, reference standard preparation, physical and chemical characterization, quality control testing, and stability determination in support of drug master file, investigational new drug, and new drug application documentation. Offerors were required to hold DEA Research Registration for Schedules II through V with capability to obtain Schedule I registration, and cGMP-compliant manufacturing facilities inspected by the FDA within two years of proposal submission.
Fisher Scientific Company LLC (Thermofisher Scientific) is the named subcontractor, providing scientific equipment and laboratory supplies. Research Triangle Institute self-performed the majority of reported labor through fiscal year 2025. Government-invoiced activity reflects 1.1 FTEs in FY2025 following 0.3 FTEs in FY2024 at a derived hourly rate of $128.22 per hour.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Fisher Scientific Company LLC | $58,446 |
Quick answers
Who was awarded contract 75N95024C00021?
75N95024C00021 was awarded to Research Triangle Institute by National Institute on Drug Abuse (National Institutes of Health) on August 4, 2024.
How much is contract 75N95024C00021 worth?
The government has obligated $1,852,395 on 75N95024C00021. Its potential value, with all options, is $7,017,379.
Was contract 75N95024C00021 competed?
The extent of competition for 75N95024C00021 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award